Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-19-000258

Options or other derivatives

  • Chief Financial Officer acquired 50,455 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hippel James Chief Financial Officer 2019-08-07 Grant or award · Restricted Stock Units +3,938 3,938 D
Hippel James Chief Financial Officer 2019-08-07 Grant or award · Stock Options (Right to Buy) +19,936 19,936 D
Hippel James Chief Financial Officer 2019-08-07 Grant or award · Stock Options (Right to Buy) +26,581 26,581 D
Loading xslF345X03/edgar.xml…